AZN vs LLY
AstraZeneca PLC · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | AZN | LLY |
|---|---|---|
| Price | $173.30 | $1,210.02 |
| Market Cap | $268.62B | $1.14T |
| P/E | 26.27 | 55.21 |
| P/B | 5.52 | 36.53 |
| P/S | 4.57 | 17.48 |
| ROE | 21.0% | 66.2% |
| Net Margin | 17.4% | 31.7% |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 1.81% | 0.51% |
| EPS | $6.60 | $21.92 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.